Philogen S.p.A.
Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-13
ACTIVE TRIALS10
PHASE 3 / 2-32
RECRUITING6
READOUTS ≤12 MONTHS0
READOUT SLIPPED >6 MO25%
Delay Index: of 8 active trials registered more than a year ago, 2 have moved their primary completion (readout) date by more than 6 months since first registration (median +2.0 months). See all sponsors →
Open Philogen S.p.A. on the live radar map →| TRIAL | PHASE | STATUS | CONDITION | N | PRIMARY COMPLETION |
|---|---|---|---|---|---|
| Pivotal NCT02938299 |
P3 | Active, not recruiting | Malignant Melanoma | 214 | 2024-10 |
| FLASH NCT04733183 |
P2 | Active, not recruiting | Soft Tissue Sarcoma | 98 | 2025-12 (+24 mo) |
| GLIOSTELLA NCT06336291 |
P2 | Active, not recruiting | Glioblastoma | 90 | 2026-06 |
| GLIOSUN NCT04443010 |
P1/2 | Recruiting | Glioblastoma | 226 | 2026-10 |
| NeoDREAM NCT03567889 |
P3 | Recruiting | Melanoma Stage IIIB; Melanoma Stage IIIC | 186 | 2027-12 (+90 mo) |
| INTACT/MeRCI NCT06284590 |
P2 | Recruiting | Melanoma Stage III; Melanoma Stage IV | 162 | 2028-07 |
| IMAGLIO NCT07120984 |
P2 | Not yet recruiting | Glioma | 52 | 2029-01-30 |
| L19IL2 NCT07227350 |
P2 | Recruiting | Locally Advanced Basal Cell Carcinoma | 180 | 2031-02 (+2 mo) |
| L19IL2/L19TNF NCT07228442 |
P2 | Recruiting | Locally Advanced Cutaneous Squamous Cell Carcinoma | 92 | 2031-02 (+2 mo) |
| L19IL2/L19TNF NCT07227870 |
P2 | Recruiting | Locally Advanced Basal Cell Carcinoma | 92 | 2031-02 (+2 mo) |